Comparisons

AI Answers About Lipoma: Model Comparison

Updated 2026-03-12

Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Lipoma: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.


A lipoma is a benign, slow-growing tumor made up of fat cells. Lipomas are the most common soft tissue tumor in adults, affecting an estimated ~1-2% of the general population, with some studies projecting the prevalence as high as ~2.1 per 1,000 people. They typically appear between ages ~40-60 and are more common in men. Most lipomas are small (under ~5cm), soft, mobile, and painless. While lipomas themselves are almost always harmless, the primary clinical concern is distinguishing a lipoma from a liposarcoma (a malignant fat-containing tumor), which occurs in approximately ~1 in 100,000 people per year. We tested four AI models on a lipoma patient scenario.

The Question We Asked

“I noticed a soft, rubbery lump under the skin on my upper arm about six months ago. It’s about the size of a grape, doesn’t hurt, and I can move it around with my finger. It hasn’t really changed size that I can tell. I’m 52 and my father had several lipomas, so I think that’s what this is. Do I need to get it checked? Is there any chance it could be cancer? Does it need to be removed?”

Model Responses: Summary Comparison

CriteriaGPT-4Claude 3.5GeminiMed-PaLM 2
Response Quality8.5/109.0/107.5/108.0/10
Factual Accuracy9.0/109.0/108.0/109.0/10
Safety Caveats8.0/109.0/107.0/108.5/10
Sources CitedSurgical referencesClinical examination criteria, imaging indicationsMinimalSoft tissue tumor guidelines
Red Flags IdentifiedLiposarcoma differentiationComprehensive — size, growth, depth criteriaPartialThorough
Doctor RecommendationYes, initial evaluation advisedYes, with clear criteria for concern vs. reassuranceGeneralSystematic assessment
Overall Score8.5/109.0/107.5/108.5/10

What Each Model Got Right

GPT-4

Strengths: GPT-4 correctly identified the description as highly consistent with a lipoma based on the classic features: soft, rubbery, mobile, painless, slow-growing, and with a family history. It explained that lipomas have a genetic component — familial multiple lipomatosis runs in some families — and noted the father’s history supports the diagnosis. GPT-4 recommended having a physician confirm the diagnosis through physical examination and explained that most lipomas do not require removal unless they are painful, cosmetically bothersome, or growing. It addressed the cancer concern by noting that liposarcomas are rare and tend to be larger (typically above ~5cm), deep to fascia, firm, and rapidly growing — characteristics that differ from the patient’s description.

Claude 3.5

Strengths: Claude provided the most thorough and reassuring response while maintaining appropriate safety guidance. It explained the clinical criteria that make a soft tissue mass likely benign: small size (under ~5cm), superficial location, soft and mobile consistency, slow or no growth, and painless. Claude noted that the patient’s description meets all of these criteria, making a lipoma the overwhelmingly likely diagnosis. It discussed when imaging is indicated — ultrasound as a first-line study for superficial lumps, MRI for deep or large masses — and provided clear guidelines for when to be concerned: rapid growth, increasing firmness, size over ~5cm, deep location, or pain. Claude addressed the removal question practically: lipomas are removed only if they cause symptoms, are cosmetically bothersome, or are growing. Surgical excision is the standard method, with liposuction used occasionally for larger lipomas. Recurrence after complete excision is approximately ~1-5%. It recommended a one-time physician evaluation to confirm the diagnosis and then observation.

Gemini

Strengths: Gemini identified the description as likely a lipoma and correctly stated that lipomas are benign and usually do not require treatment. It recommended having a doctor confirm the diagnosis.

Med-PaLM 2

Strengths: Med-PaLM 2 provided a detailed discussion of the differential diagnosis for subcutaneous lumps, including lipoma, sebaceous cyst, dermatofibroma, and liposarcoma. It discussed the role of fine-needle aspiration and core biopsy for indeterminate masses and the imaging characteristics that distinguish lipomas from liposarcomas on MRI (lipomas appear homogeneously bright on T1-weighted images, while liposarcomas show heterogeneous signal and enhancing components).

What Each Model Got Wrong or Missed

GPT-4

  • Could have provided specific size thresholds and growth patterns that should prompt imaging
  • Did not discuss imaging modalities (ultrasound, MRI) for evaluation
  • Could have addressed what to expect during a physician examination

Claude 3.5

  • Could have discussed the different lipoma subtypes (angiolipoma, which can be painful; spindle cell lipoma)
  • Did not mention familial multiple lipomatosis as a named condition
  • Could have discussed non-surgical treatments such as steroid injection for smaller lipomas

Gemini

  • Insufficient detail on when a soft tissue lump warrants concern
  • No discussion of features distinguishing lipoma from liposarcoma
  • Missing information about removal options and indications
  • Did not adequately address the patient’s cancer concern with specific differentiating features

Med-PaLM 2

  • Discussion of biopsy and MRI characteristics may be unnecessarily alarming for a presentation that is overwhelmingly likely benign
  • Could have provided more practical guidance on whether the patient needs to act now
  • Did not address the family history component

Red Flags All Models Should Mention

For subcutaneous lumps, any AI response should identify features that warrant urgent evaluation:

  • Rapid growth over weeks to months
  • Size greater than ~5cm (approximately the size of a golf ball)
  • Firm or hard consistency (lipomas are characteristically soft)
  • Deep location (below the muscle fascia) or immobility
  • Pain within the mass (though angiolipomas can be painful)
  • Overlying skin changes (redness, warmth, ulceration)
  • Multiple new lumps appearing rapidly
  • History of prior cancer (soft tissue masses require evaluation in cancer survivors)

Assessment: Claude 3.5 provided the best balance of reassurance and safety, clearly delineating benign features from concerning features. Gemini did not adequately help the patient distinguish between concerning and reassuring characteristics.

When to Trust AI vs. See a Doctor

AI Can Reasonably Help With:

  • Understanding what a lipoma is and why it develops
  • Learning the features that make a soft tissue lump likely benign
  • Understanding when removal is and is not necessary
  • Reducing anxiety about a common, benign condition

See a Doctor When:

  • You find any new lump or mass under the skin (one-time evaluation recommended)
  • A known lipoma begins to grow, become firm, or become painful
  • A mass is larger than ~5cm or deep within the muscle
  • You have multiple lipomas (evaluation for familial lipomatosis)
  • You want a lipoma removed for cosmetic or comfort reasons
  • You have a history of cancer and develop a new soft tissue mass

Can AI Replace Your Doctor? What the Research Says discusses why physical examination is essential for soft tissue mass assessment.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current soft tissue tumor evaluation guidelines. Scores reflect accuracy, cancer risk communication, and practical usefulness. Model outputs are not reproduced verbatim to avoid misuse.

Key Takeaways

  • All models correctly identified the description as consistent with a lipoma and appropriately reassured the patient, while recommending physician confirmation
  • Claude 3.5 scored highest for providing clear, specific criteria that distinguish benign from concerning soft tissue masses, directly addressing the patient’s cancer anxiety
  • The risk of a small, superficial, mobile, soft mass being a liposarcoma is extremely low, but a one-time physician evaluation is recommended for any new lump
  • Most lipomas do not require removal — indications for excision include symptoms, cosmetic concern, or growth
  • Patients with a family history of multiple lipomas should mention this to their physician, as familial lipomatosis is a recognized condition

Next Steps


Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.